Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bacterial Adhesion | 4 | 2019 | 69 | 1.31 | Why? |
| Staphylococcus aureus | 6 | 2019 | 844 | 1.28 | Why? |
| Coagulase | 5 | 2019 | 44 | 0.93 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.85 | Why? |
| Itraconazole | 1 | 2021 | 135 | 0.80 | Why? |
| Fibronectins | 2 | 2018 | 92 | 0.72 | Why? |
| Endocarditis, Bacterial | 2 | 2019 | 344 | 0.67 | Why? |
| Aortic Valve | 1 | 2019 | 664 | 0.50 | Why? |
| Hemostasis | 1 | 2018 | 811 | 0.44 | Why? |
| Fibrin | 3 | 2019 | 145 | 0.38 | Why? |
| von Willebrand Factor | 4 | 2019 | 668 | 0.38 | Why? |
| Platelet Membrane Glycoproteins | 2 | 2019 | 42 | 0.38 | Why? |
| Proof of Concept Study | 2 | 2021 | 696 | 0.23 | Why? |
| Disease Models, Animal | 5 | 2021 | 10998 | 0.21 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.21 | Why? |
| STAT2 Transcription Factor | 1 | 2020 | 141 | 0.20 | Why? |
| Human Umbilical Vein Endothelial Cells | 2 | 2018 | 286 | 0.19 | Why? |
| Yellow Fever Vaccine | 1 | 2020 | 198 | 0.19 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.18 | Why? |
| Metalloendopeptidases | 1 | 2018 | 35 | 0.18 | Why? |
| Plasminogen | 1 | 2018 | 58 | 0.17 | Why? |
| Pipecolic Acids | 1 | 2018 | 84 | 0.17 | Why? |
| Mesentery | 1 | 2017 | 43 | 0.17 | Why? |
| Blood Platelets | 2 | 2019 | 1704 | 0.17 | Why? |
| Standard of Care | 2 | 2021 | 1297 | 0.16 | Why? |
| Hemostatics | 1 | 2018 | 142 | 0.16 | Why? |
| Dabigatran | 1 | 2018 | 204 | 0.15 | Why? |
| Endothelium | 1 | 2019 | 460 | 0.15 | Why? |
| Vaccines, Attenuated | 1 | 2020 | 952 | 0.14 | Why? |
| Thrombin | 1 | 2018 | 325 | 0.14 | Why? |
| ADAMTS13 Protein | 1 | 2018 | 363 | 0.14 | Why? |
| Antithrombins | 1 | 2018 | 353 | 0.14 | Why? |
| Platelet Activation | 1 | 2018 | 660 | 0.13 | Why? |
| Mice | 5 | 2020 | 21357 | 0.13 | Why? |
| Belgium | 4 | 2021 | 2064 | 0.13 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.13 | Why? |
| Genetic Vectors | 1 | 2020 | 1600 | 0.13 | Why? |
| Blood Vessels | 1 | 2015 | 228 | 0.13 | Why? |
| Fibrinolysis | 1 | 2018 | 521 | 0.12 | Why? |
| Bacteriological Techniques | 1 | 2015 | 239 | 0.12 | Why? |
| Venous Thromboembolism | 2 | 2021 | 4273 | 0.12 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.12 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.12 | Why? |
| Enoxaparin | 1 | 2018 | 1064 | 0.11 | Why? |
| Animals | 8 | 2021 | 78931 | 0.10 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.10 | Why? |
| Amides | 1 | 2020 | 1864 | 0.09 | Why? |
| Cricetinae | 3 | 2020 | 3344 | 0.09 | Why? |
| Immunization, Passive | 2 | 2022 | 10067 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Immune System | 1 | 2018 | 1479 | 0.09 | Why? |
| Plasma | 1 | 2018 | 1809 | 0.09 | Why? |
| Blood Coagulation | 2 | 2018 | 2768 | 0.09 | Why? |
| Stress, Mechanical | 2 | 2018 | 143 | 0.09 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.08 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.08 | Why? |
| Protein Binding | 3 | 2018 | 11430 | 0.08 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.07 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.07 | Why? |
| Treatment Outcome | 6 | 2022 | 51732 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.07 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| Safety | 2 | 2020 | 1583 | 0.06 | Why? |
| Aprotinin | 1 | 2020 | 63 | 0.05 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2018 | 2134 | 0.05 | Why? |
| Kallikreins | 1 | 2020 | 158 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Lactococcus lactis | 1 | 2018 | 45 | 0.05 | Why? |
| Adhesins, Bacterial | 1 | 2018 | 39 | 0.05 | Why? |
| Bradykinin | 1 | 2020 | 203 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2022 | 51949 | 0.05 | Why? |
| Aminoacyltransferases | 1 | 2017 | 10 | 0.04 | Why? |
| Splanchnic Circulation | 1 | 2017 | 37 | 0.04 | Why? |
| Male | 8 | 2021 | 367725 | 0.04 | Why? |
| Female | 8 | 2021 | 380317 | 0.04 | Why? |
| Global Burden of Disease | 1 | 2020 | 531 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Partial Thromboplastin Time | 1 | 2018 | 436 | 0.04 | Why? |
| Glycosylation | 1 | 2020 | 1255 | 0.04 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.04 | Why? |
| Macaca fascicularis | 1 | 2020 | 1009 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.04 | Why? |
| Thrombosis | 1 | 2018 | 7504 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2015 | 335 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Fibrinogen | 1 | 2018 | 1048 | 0.03 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2015 | 1027 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.03 | Why? |
| Humans | 10 | 2022 | 930598 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Prospective Studies | 3 | 2022 | 43301 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.03 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Cysteine Endopeptidases | 1 | 2017 | 1557 | 0.02 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.02 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.02 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2021 | 243684 | 0.01 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Lung | 2 | 2020 | 31049 | 0.01 | Why? |
| Hospitalization | 2 | 2022 | 54280 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Adult | 3 | 2022 | 244371 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2022 | 25288 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Liesenborghs's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(180)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_